[144] Concentrix Corporation SEC Filing

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	300000	18150000	63025120	07/08/2025	NASD

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/25/2023	Acquired as consideration of merger or acquisition	Issuer			150000	09/25/2023	Securities
Common Stock	09/25/2023	Acquired as consideration of merger or acquisition	Issuer			150000	09/25/2023	Securities

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Liberty Management 39899 Balentine Drive Suite 235 Newark CA 94560	Common stock	04/15/2025	19366	943118.39
Olivier Fabrice Duha 39899 Balentine Drive Suite 235 Newark CA 94560	Common stock	04/15/2025	29444	1428684.71
Celeste Investissements 39899 Balentine Drive Suite 235 Newark CA 94560	Common stock	04/15/2025	29706	1441465.83
Olivier Fabrice Duha 39899 Balentine Drive Suite 235 Newark CA 94560	Common stock	04/16/2025	11512	554870.34
Liberty Management 39899 Balentine Drive Suite 235 Newark CA 94560	Common stock	04/16/2025	7176	345934.15
Celeste Investissements 39899 Balentine Drive Suite 235 Newark CA 94560	Common stock	04/16/2025	11639	560905.52
Olivier Fabrice Duha 39899 Balentine Drive Suite 235 Newark CA 94560	Common stock	07/02/2025	20251	1145570.72
Liberty Management 39899 Balentine Drive Suite 235 Newark CA 94560	Common stock	07/02/2025	9499	535930.73
Celeste Investissements 39899 Balentine Drive Suite 235 Newark CA 94560	Common stock	07/02/2025	20250	1145499.98
Olivier Fabrice Duha 39899 Balentine Drive Suite 235 Newark CA 94560	Common stock	07/08/2025	70773	4275963.11
Celeste Investissements 39899 Balentine Drive Suite 235 Newark CA 94560	Common stock	07/08/2025	70384	4250334.92

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)